Speeding New Therapies to Market
BMS turned scattered, inconsistent product data into one trusted foundation, so new therapies reach the market faster and every team works from the same facts.
Challenge
Bringing a therapy to market means aligning data across research, supply, and commercial. When each team defined it differently, every handoff became a reconciliation exercise, delaying launches and putting revenue and compliance at risk.
Solution
BMS built a governed context layer: one authoritative model of product and reference data that every system draws on. When a therapy launches or its data changes, the update flows everywhere automatically, keeping research, supply, and commercial in lockstep.
Technical approach
- One canonical model of product and reference data, so the same thing means the same thing across research, supply, and commercial
- AI-drafted, expert-approved, and kept governed and current
- Integrates with Neo4j and AWS DataZone
Results
- Launches 30-50% faster, as data syncs across systems from day one
- Compliance risk down sharply, from consistent and traceable data across the lifecycle
- Duplicated data work cut 20-40%, because every team builds on one source